GlassScriptPhysician profile
Scott Gregory Bird
NPI 1992200331
$3,313.63
in general payments reported to CMS, 2019-2025
17 companies · $350 in 2025
The $350 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2021: $1,377 · 2022: $511 · 2023: $313 · 2024: $327 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $989.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impactortho, INC. | $1,200.00 | 2021 | |
| Stryker Corporation | $917.64 | 2021-2025 | Prophecy, Augment Injectable, T2 Alpha |
| Sportstek Medical, INC | $436.00 | 2019 | |
| Medline Industries LP | $139.74 | 2025 | |
| Sawtooth Surgical Solutions INC | $119.37 | 2024-2025 | |
| Polynovo North America LLC | $115.86 | 2022-2024 | Novosorb Btm |
| Treace Medical Concepts, INC. | $75.05 | 2023-2025 | |
| Kerecis Limited | $62.97 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Midsouth Orthopedics INC. | $46.87 | 2021 | |
| Alfasigma USA, INC. | $33.18 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $29.88 | 2022 | |
| Amgen INC. | $27.48 | 2024 | Krystexxa |
| Depuy Synthes Sales INC. | $27.13 | 2021-2022 | |
| Kci USA, INC. | $25.31 | 2023 | V.A.C. Dermatac, Promogran Prisma, Activ.A.C. |
| Djo, LLC | $23.28 | 2024 | Cmf |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $19.61 | 2022 | |
| Paratek Pharmaceuticals, INC. | $14.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Bird listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.